Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torasemide prolonged-release versus immediate-release in mild to moderate hypertension
2004-000876-14Phase 4Active
- Sponsor
- Ferrer
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of torasemide in hypertension (HTN) (2 arms), sponsored by Ferrer. Primary endpoint: Change in diastolic pressure. Started Dec 2005; status: active.
02
Drugs
torasemide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2004-000876-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000876-14.